|
| Question | (%) |
|
| Status of vitamin D deficiency in India | |
| Only in high risk groups | 60 (23.8) |
| Urban population | 119 (47.2) |
| Epidemic proportions | 45 (17.8) |
| Rare | 21 (8.3) |
| High risk groups for vitamin D deficiency | |
| Infants, pregnant, and lactating women | 192 (76.1) |
| Elderly | 15 (5.9) |
| Patients with diabetes mellitus | 6 (2.3) |
| People with naturally fair skin | 23 (9.1) |
| None of the above | 16 (6.3) |
| Problems associated with vitamin D deficiency | |
| Bone and skeletal disorders | 238 (94.4) |
| Diabetes mellitus | 2 (0.7) |
| Cardiovascular disease | 1 (0.3) |
| Cancer | 1 (1.1) |
| Autoimmune disorders | 4 (1.5) |
| None of the above | 2 (0.7) |
| Sources of vitamin D | |
| Green leafy vegetables | 43 (17.0) |
| Sunlight that passed through glass | 83 (48.0) |
| Milk | 57 (22.6) |
| Egg yolk | 21 (8.3) |
| None of the above | 10 (3.9) |
| Adequate sun exposure to achieve sufficient vitamin D levels in New Delhi | |
| Sun exposure (10 am–2 pm) on exposed arms and legs | 107 (42.4) |
| Sunlight passed through glass (10 am–2 pm) on exposed arms and legs | 46 (18.2) |
| Sunlight exposure through glass (2–4 pm) on exposed arms and legs | 9 (3.5) |
| Sun exposure (7 am–10 am) on exposed arms and legs | 79 (31.3) |
| None of the above | 11 (4.3) |
| Minimum amount of sun exposure required for synthesis of vitamin D in New Delhi | |
| 1 hour/day | 87 (34.5) |
| 30 min/twice a week | 81 (32.1) |
| 2 hours a day | 51 (20.2) |
| 4 hour/twice a week | 24 (8.7) |
| None of the above | 11 (4.3) |
| RDA of vitamin D | |
| 600 IU | 62 (24.6) |
| 800 IU | 84 (33.3) |
| 1000 IU | 55 (21.8) |
| 2000 IU | 13 (5.1) |
| Ever taken vitamin D supplement | |
| No | 58 (23) |
| Yes, with estimation of serum 25-hydroxyvitamin D levels | 61 (24.2) |
| Yes, without estimation of serum 25-hydroxyvitamin D levels | 132 (52.3) |
| Recommended form of vitamin D supplement for nutritional deficiency | |
| Alfacalcidol | 19 (7.5) |
| Cholecalciferol | 101 (40.0) |
| Calcitriol | 105 (41.6) |
| Either of the above | 22 (8.7) |
| None of the above | 5 (1.9) |
| Active biochemical form of vitamin D | |
| Alfacalcidol | 2 (0.7) |
| Calcitriol | 133 (52) |
| Cholecalciferol | 99 (39.2) |
| Ergocalciferol | 7 (2.7) |
| None of the above | 18 (7.1) |
| Vitamin D serum levels in an adult indicate | |
| Insufficiency at 20–29 ng/mL; deficiency ≤20 ng/mL | 46 (18) |
| Insufficiency at 10–19 ng/mL; deficiency ≤15 ng/mL | 50 (19.8) |
| Insufficiency at 20–29 ng/mL; deficiency at ≤30 ng/mL | 56 (22.2) |
| Insufficiency at 20–29 ng/mL; deficiency at ≤10 ng/mL | 35 (13.8) |
| None of the above | 65 (25.7) |
| Dose regime of vitamin D3 recommended for treatment of vitamin D deficiency | |
| 50,000 IU of vitamin D3 once a week for 6–8 weeks | 69 (27.3) |
| 60,000 IU once a week for 8 weeks | 29 (11.5) |
| 5000 IU once a week for 10 weeks | 86 (34.1) |
| 8000 IU/day for 6 months | 22 (8.7) |
| None of the above | 46 (18.2) |
| Biochemical form of vitamin D most commonly associated with hypercalcemia and hypervitaminosis | |
| Calcitriol | 84 (33.3) |
| Alfacalcidol | 37 (14.6) |
| Cholecalciferol | 105 (41.6) |
| None of the above | 37 (14.6) |
| Are calcium supplements required for all in treatment of vitamin D deficiency | |
| Yes | 164 (65) |
| No | 88 (34.9) |
|
